Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 28, 2012PLoS ONEOpen Access

Coadministration of Lopinavir/Ritonavir and Rifampicin in HIV and Tuberculosis Co-Infected Adults in South Africa

View Full Paper
Ask AI
Bookmark
Share

Authors

RMRichard A. MurphyUniversity of Southern CaliforniaVMVincent C. MarconiEmory UniversityRGRajesh T. GandhiHarvard University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Murphy et al. (2012) studied this question.

synapsesocial.com/papers/6aac8f6c130ffbe2130775e0https://doi.org/10.1371/journal.pone.0044793
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Therapeutic Implications of Drug Interactions in the Treatment of Human Immunodeficiency Virus‐Related Tuberculosis1999 · 155 citations
  2. 2Outcomes after virologic failure of first-line ART in South Africa2010 · 69 citations
  3. 3Pharmacokinetics of Adjusted-Dose Lopinavir-Ritonavir Combined with Rifampin in Healthy Volunteers2004 · 184 citations
  4. 4HIV-Infected Patients Receiving Lopinavir/Ritonavir-Based Antiretroviral Therapy Achieve High Rates of Virologic Suppression Despite Adherence Rates Less Than 95%2007 · 154 citations